ArticleBMJ open2026
Intrauterine infusion of autologous platelet-rich plasma (PRP) versus granulocyte colony-stimulating factor (G-CSF) prior to single frozen blastocyst transfer in women with thin endometrium: a study protocol for a multicentre sequential multiple assignment randomised trial.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionA thin endometrium (TE) is associated with reduced reproductive potential, including lower implantation rates and increased obstetric risks. While intrauterine infusion of autologous platelet-rich plasma (PRP) or granulocyte colony-stimulating factor (G-CSF) is commonly used, robust evidence for their efficacy remains lacking. This trial aims to compare the effectiveness of PRP versus G-CSF in women with TE using a sham-controlled, sequential multiple assignment randomised trial (SMART) design. METHODS AND ANALYSIS: This is a triple-blind, multicentre SMART study conducted at four tertiary fertility centres in China. We will recruit 440 women undergoing single frozen blastocyst transfer with a history of TE (endometrial thickness <8 mm). Participants will be randomly assigned (1:1:2) to receive intrauterine infusion of PRP, G-CSF or a sham procedure (stage 1). Infusions are performed twice per cycle: when the leading follicle reaches 13-14 mm in natural frozen embryo transfer (FET) cycles or stimulated FET cycles, or on day 8 of oestradiol administration in artificial FET cycles, repeated 48 hours later. The primary outcome is the live birth rate from the first embryo transfer (Stage 1). Secondary outcomes include changes in endometrial thickness, clinical pregnancy rates and neonatal outcomes. Participants in the sham group who do not achieve a live birth will be re-randomised (1:1) to receive either PRP or G-CSF for their subsequent transfer (Stage 2). Data analysis will follow the intention-to-treat principle. ETHICS AND DISSEMINATION: The study protocol was approved by the ethics committees of The First Affiliated Hospital of Sun Yat-sen University ((2025)211-1), Boai Hospital of Zhongshan (AF/SC-07/03.1), The First People's Hospital of Foshan ((2026)146) and Foshan Maternity and Child Healthcare Hospital (FSFY-MEC-2026-161). All participants will provide written informed consent. Results will be published in peer-reviewed journals and presented at scientific congresses. TRIAL REGISTRATION NUMBER: ChiCTR2500108620.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.